These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

175 related items for PubMed ID: 9806337

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Cannabinoid receptor agonists inhibit Ca(2+) influx to synaptosomes from rat brain.
    Yoshihara S, Morimoto H, Ohori M, Yamada Y, Abe T, Arisaka O.
    Pharmacology; 2006; 76(4):157-62. PubMed ID: 16446560
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Effects of the endogeneous cannabinoid, anandamide, on neuronal activity in rat hippocampal slices.
    Ameri A, Wilhelm A, Simmet T.
    Br J Pharmacol; 1999 Apr; 126(8):1831-9. PubMed ID: 10372827
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Involvement of CB1 and CB2 receptors in the modulation of cholinergic neurotransmission in mouse gastric preparations.
    Mulè F, Amato A, Baldassano S, Serio R.
    Pharmacol Res; 2007 Sep; 56(3):185-92. PubMed ID: 17656103
    [Abstract] [Full Text] [Related]

  • 27. Hydrogen peroxide as a mediator of vasorelaxation evoked by N-oleoylethanolamine and anandamide in rat small mesenteric arteries.
    Wheal AJ, Alexander SP, Randall MD.
    Eur J Pharmacol; 2012 Jan 15; 674(2-3):384-90. PubMed ID: 22154756
    [Abstract] [Full Text] [Related]

  • 28. Vasorelaxant activities of the putative endocannabinoid virodhamine in rat isolated small mesenteric artery.
    Ho WS, Hiley CR.
    J Pharm Pharmacol; 2004 Jul 15; 56(7):869-75. PubMed ID: 15233865
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. A role for N-arachidonylethanolamine (anandamide) as the mediator of sensory nerve-dependent Ca2+-induced relaxation.
    Ishioka N, Bukoski RD.
    J Pharmacol Exp Ther; 1999 Apr 15; 289(1):245-50. PubMed ID: 10087011
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. 'Entourage' effects of N-palmitoylethanolamide and N-oleoylethanolamide on vasorelaxation to anandamide occur through TRPV1 receptors.
    Ho WS, Barrett DA, Randall MD.
    Br J Pharmacol; 2008 Nov 15; 155(6):837-46. PubMed ID: 18695637
    [Abstract] [Full Text] [Related]

  • 35. Anandamide and WIN 55212-2 inhibit cyclic AMP formation through G-protein-coupled receptors distinct from CB1 cannabinoid receptors in cultured astrocytes.
    Sagan S, Venance L, Torrens Y, Cordier J, Glowinski J, Giaume C.
    Eur J Neurosci; 1999 Feb 15; 11(2):691-9. PubMed ID: 10051770
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Evidence that anandamide and EDHF act via different mechanisms in rat isolated mesenteric arteries.
    Plane F, Holland M, Waldron GJ, Garland CJ, Boyle JP.
    Br J Pharmacol; 1997 Aug 15; 121(8):1509-11. PubMed ID: 9283682
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Involvement of the peroxisome proliferator-activated receptor (PPAR) alpha in vascular response of endocannabinoids in the bovine ophthalmic artery.
    Romano MR, Lograno MD.
    Eur J Pharmacol; 2012 May 15; 683(1-3):197-203. PubMed ID: 22429572
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.